Sun Pharma: Full Form, Profile, Latest Revenue and Financials Details

Company profile is the section where you can have a brief description about well established and financially sound companies that are listed in the Indian Stock Exchanges. This section will provide a keen overview about the company in terms of its origin, founders, latest financial reports and much more. We will try to make this article as informative as possible so that virtually this page becomes the Sun Pharma Wiki for a stock market beginner.

This week we would be exploring Sun Pharma who is one of the highly reputed multinational pharmaceutical company which primarily operates in India and United States.

Companies Origin & Profile:

Brief Company Profile:

Sun Pharma Industries was established in the year 1983 in Vapi, Gujarat Within the 2 years span it has extended its sales throughout nation. Subsequently the company has launched cardiology drugs in the year 1987 accompanied by gastroenterology drugs in the year 1989. With global revenues of US$ 4.5 billion, Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. Mainly markets outside India contributes to over 72% of Sun Pharma sales US is the sole gigantic market, considering about 50% business; in all, 93% of turnover is captured by finished dosage forms and formulations.

Inception & Founders:

Sun Pharma Industries was incorporated by Mr Dilip Shanghvi. Starting with five products that were used to cure psychiatry ailments.

Chairman & Directors:

Mr Israel Makov is the Chairman and Mr Dilip Shanghvi is the managing director of Sun Pharma Industries Limited.

Customer Segment & Area of Operations:

Sun Pharma has a diverse and highly independent portfolio of speciality and generic products focusing on a vast range of acute and chronic treatments. Its products cover the full range of ointments, capsules, tablets, liquids and creams. The remedical segments consists of more than 2000 high quality molecules which consists of neurology, urology, gastroenterology, diabetology, dental and nutritionals among others. Besides this it also capable of manufacturing Active Pharmaceutical Ingredients(APIs), anti- retrovirals(ARV’s) and over-the-counter(OTC) among others.

Confidence Booster for Investors:

The following pointers will uplift the confidence of any stock market analyst. As this highlight the favourable business outcomes for Sun Pharma.

  • Sales growth for the past 3 years has been at 25.22 %.
  • Having highest market cap in the pharma industry at Rs 140564.43 Cr.
  • The compounded profit growth of the past 5 years at been at 23.02%.

Quick Financial Information(Last Updated on 02/08/2018):

Following table highlights Key ratios and financial variables which will help investors a lot.

Particulars Info
Current Price: 585.85
52 weeks High / Low 608.55 / 433.15
Market Cap: 140,564 Cr.
Stock P/E: 41.38
Face Value 1
ROCE: 21.01 %
Book Value: 163.58
Dividend Yield: 0.60 %
Sales Growth (3Yrs): 25.22 %
Listed on BSE and NSE
ROE: 19.86 %

Shareholding pattern:

The table below highlights the approximate shareholding pattern of Sun Pharma.

Holder’s Name % Shareholding
Promoters 54.38%
Foreign Institutions 16.40%
Banks and Mutual Funds 8.41%
Financial Institutions 8.17%
General Public 6.97%
Others 5.67%

Peer Comparison:

The table below highlights the Top 7 companies in the same business, therefore, giving the easy benchmark for comparing Sun Pharma with other 6 companies in the same business.

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Sales Qtr Rs.Cr. Qtr Sales Var % ROCE %
1 Piramal Enterp. 2,794 10 50,465 1 -69.81 -33.36 2902.49 29.24 28.33
2 Sun Pharma.Inds. 586 41 140,564 1 1528.99 10.35 6977.1 -2.24 21.01
3 Unichem Labs. 236.4 0.66 1662.91 2.11 -20.65 -1476.67 201.43 42.54 -15.38
4 Aurobindo Pharma 623.15 15.07 36510.83 0.4 528.51 -0.74 4049.09 11.19 27.6
5 Cadila Health. 377.3 21.75 38625.81 0.93 590.8 53.26 3250.2 31.77 21.04
6 Lupin 886 25.33 40060.78 0.56 -777.6 42.48 4033.83 -5.16 11.24
7 Claris Lifescien 396.55 1.37 2163.88 0.5 -317.43 -1809.37 2.07 -54.51 -10.91

Annual & Quarterly Results:
Below is the Quarterly Results of Sun Pharma

Mar 2018 Dec 2017 Sep 2017 Jun 2017 Mar 2017 Dec 2016
Sales 6,977 6,653 6,650 6,208 7,136 7,925
Expenses 5,293 5,199 5,274 6,063 5,589 5,471
Operating Profit 1,683 1,453 1,375 145 1,547 2,453
OPM % 24.13% 21.84% 20.68% 2.34% 21.68% 30.95%
Other Income 302 129 254 151 224 122
Depreciation 455 339 358 346 338 306
Interest 155 95 157 109 44 166
Profit before tax 1,375 1,147 1,114 -158 1,388 2,102
Tax -176 748 111 161 44 372
Net Profit 1,528 400 1,001 -322 1,385 1,721

Annual Results of Sun Pharma

Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Mar 2012
Sales 31,578 28,487 27,392 16,080 11,130 8,019
Expenses 21,489 21,013 19,763 11,598 6,824 4,816
Operating Profit 10,089 7,473 7,628 4,482 4,306 3,203
OPM % 31.95% 26.23% 27.85% 27.87% 38.69% 39.94%
Other Income 623 658 547 552 388 471
Interest 399 523 578 44 43 28
Depreciation 1,264 1,037 1,194 409 336 291
Profit before tax 9,047 6,570 6,402 4,581 4,314 3,355
Tax 1,211 913 914 702 845 313
Net Profit 6,964 4,545 4,539 3,141 2,983 2,656

Cash Flow statement:

Readers will find the cash flow statements of Sun Pharma of past 6 years.

Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Mar 2012
Cash from Operating Activity 7,082 6,685 5,615 3,959 3,356 2,234
Cash from Investing Activity -4,186 -3,949 -1,502 -2,176 -2,375 -747
Cash from Financing Activity -2,285 -1,888 -1,186 506 -664 -544
Net Cash Flow 610 848 2,926 2,289 316 942

Balance Sheet:
The below table highlights the balance sheet position of Sun Pharma for the past 6 years.

Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013 Mar 2012
Share Capital 239 240 207 207 103 103
Reserves 36,399 32,741 25,378 18,317 14,886 12,132
Borrowings 9,831 8,496 8,996 2,560 259 320
Other Liabilities 15,440 14,463 14,635 8,298 5,343 3,945
Total Liabilities 61,911 55,941 49,217 29,384 20,592 16,502
Fixed Assets 17,675 15,872 12,682 6,817 5,647 3,951
CWIP 2,801 2,175 2,038 841 562 344
Investments 1,191 1,829 2,716 2,786 2,411 2,212
Other Assets 40,243 36,064 31,780 18,939 11,971 9,993
Total Assets 61,911 55,941 49,217 29,384 20,592 16,502

For more useful articles on trading, investing and market knowledge, visit our Knowledge Center section.

(Note: The above list is for information purpose only. Avoid trading and investing based on the information given above. Before investing in stocks do due diligence).

Leave A Comment?